Evidence map›Paper›PMID 39602797›Full record

ArticleBioinformatics (Oxford, England)2024

Phasing nanopore genome assembly by integrating heterozygous variations and Hi-C data.

Jun Zhang, Fan Nie, Feng Luo, Jianxin Wang

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jun ZhangSchool of Computer Science and Engineering, Central South University, Changsha, Hunan 410083, China.
Fan NieSchool of Computer Science and Engineering, Central South University, Changsha, Hunan 410083, China.
Feng LuoSchool of Computing, Clemson University, Clemson, SC 29634-0974, United States.ORCID 0000-0002-4813-2403
Jianxin WangSchool of Computer Science and Engineering, Central South University, Changsha, Hunan 410083, China.ORCID 0000-0003-1516-0480

Funding

National Natural Science Foundation of China 62350004Project of Xiangjiang Laboratory 23XJ01011
6 · The paper itself

Abstract

motivationHaplotype-resolved genome assemblies serve as vital resources in various research domains, including genomics, medicine, and pangenomics. Algorithms employing Hi-C data to generate haplotype-resolved assemblies are particularly advantageous due to its ready availability. Existing methods primarily depend on mapping quality to filter out uninformative Hi-C alignments which may be susceptible to sequencing errors. Setting a high mapping quality threshold filters out numerous informative Hi-C alignments, whereas a low mapping quality threshold compromises the accuracy of Hi-C alignments. Maintaining high accuracy while retaining a maximum number of Hi-C alignments can be challenging.

resultsIn our experiments, heterozygous variations play an important role in filtering uninformative Hi-C alignments. Here, we introduce Diphase, a novel phasing tool that harnesses heterozygous variations to accurately identify the informative Hi-C alignments for phasing and to extend primary/alternate assemblies. Diphase leverages mapping quality and heterozygous variations to filter uninformative Hi-C alignments, thereby enhancing the accuracy of phasing and the detection of switches. To validate its performance, we conducted a comparative analysis of Diphase, FALCON-Phase, and GFAse on various human datasets. The results demonstrate that Diphase achieves a longer phased block N50 and exhibits higher phasing accuracy while maintaining a lower hamming error rate. AVAILABILITY AND IMPLEMENTATION: The source code of Diphase is available at https://github.com/zhangjuncsu/Diphase.

Indexed as

AlgorithmsGenome, HumanGenomicsHaplotypesHeterozygoteHumansNanoporesSequence Analysis, DNASoftware

Identifiers

PMID39602797
PMCPMC11663803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.